MVMargreet C. Vos

Margreet C. Vos

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Margreet C. Vos has a total of 277 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Predictive value of rectal and throat–nose screening for the presence of multi-drug-resistant organisms in duodenal fluid as a risk of duodenoscope contamination: a multi-centre study

    by Koen van der Ploeg, Margreet C. Vos, Saskia H.J. Renkens, Bibi C.G.C. Mason-Slingerland, Corné H.W. Klaassen, Hardik Rughwani, Duvvur Nageshwar Reddy, Sadhana Y. Veturi, Ravikanth Vishnubhotla, Sana F. Memon, et al.

  • Open Access

    One Health Perspective on Sources and Transmission Routes of Carbapenem-Resistant Pseudomonas aeruginosa: A Cross-Sectional Study

    by Anneloes van Veen, Selvi N. Shahab, Amber Rijfkogel, Anne F. Voor In &Apos;T Holt, C.H.W. Klaassen, Margreet C. Vos, Yulia Rosa Saharman, Anis Karuniawati, Silvia Zelli, Desy De Lorenzis, et al.

    Background: Carbapenem-resistant Pseudomonas aeruginosa (CRPA) poses a global health risk, yet there is insufficient knowledge about its sources and transmission routes within an integrated One Health framework. This study aimed to investigate CRPA presence and dynamics at the human-water interface inside and outside hospitals in three major cities located in different climatic zones. Methods: This cross-sectional study was conducted in Rotterdam (The Netherlands), Rome (Italy), and Jakarta (Indonesia) between March 2022 and June 2024. Samples were collected from humans, hospital environments, and various water sources. CRPA isolates underwent sequencing to determine carbapenemase gene presence and their genetic relatedness. Primary outcomes included CRPA carriage in healthy individuals and newly hospitalized patients, CRPA prevalence in hospital environments, CRPA concentrations in aquatic environments, and the frequency and transmission likelihood within epidemiological clusters. Findings: CRPA carriage was detected in 0·5% (1/194) of healthy individuals from Rotterdam, 0·0% (0/245) from Rome, and 0·8% (2/250) from Jakarta. Among patients, CRPA carriage differed significantly across cities (P<0·001), with 0·4% (2/469) in Rotterdam, 0·3% (1/363) in Rome, and 4·8% (28/584) in Jakarta. In wet hospital environments, CRPA prevalence ranged between 0·0% (Rome) and 13·4% (Jakarta). CRPA concentrations were highest in hospital wastewater and remained detectable in treated effluent of municipal wastewater treatment plants (mWWTP) and the receiving river in all cities. Carbapenemase genes were detected in 25·9% (100/386) of isolates. CRPA isolates identified in the clinical setting clustered with those from mWWTP influent or effluent (Rotterdam) or the river (Jakarta). High genetic diversity, overall and within reservoirs, was observed among isolates. Interpretation: The substantial presence of CRPA in environmental reservoirs, along with the cross-over between them, may pose a public health risk, and warrant mitigation strategies. To prevent CRPA transmission within hospitals and limit cross-sectoral transmission, robust infection prevention and control measures, alongside effective wastewater treatment, are essential.

  • Open Access

    Evaluating the risk of duodenoscope-associated colonization and duodenoscope-associated infection: a prospective observational study

    by K. van der Ploeg, C.H.W. Klaassen, S.H.J. Renkens, B.C.G.C. Mason-Slingerland, J.A. Severin, M.J. Bruno, M.C. Vos


  • Open Access

    Sources and Transmission Routes of Carbapenem-Resistant Pseudomonas aeruginosa: Study Design and Methodology of the SAMPAN Study

    by Anneloes van Veen, Selvi N. Shahab, Amber Rijfkogel, Anne F. Voor In ’T Holt, Corné H. W. Klaassen, Margreet C. Vos, Yulia Rosa Saharman, Anis Karuniawati, Silvia Zelli, Desy De Lorenzis, et al.

    Background/Objectives: The global spread of carbapenem-resistant Pseudomonas aeruginosa (CRPA) warrants collaborative action. Guidance should come from integrated One Health surveillance; however, a surveillance strategy is currently unavailable due to insufficient knowledge on the sources and transmission routes of CRPA. The aim of the SAMPAN study (“A Smart Surveillance Strategy for Carbapenem-resistant Pseudomonas aeruginosa”) is to develop a globally applicable surveillance strategy. Methods: First, an international cross-sectional study will be conducted to investigate CRPA in clinical and environmental settings in Rotterdam (The Netherlands), Rome (Italy), and Jakarta (Indonesia). Screening cultures and risk factor questionnaires will be taken from healthy individuals and patients upon hospital admission. Clinical CRPA isolates will also be included. Additionally, samples will be taken twice from wet hospital environments and monthly from the hospitals’ (drinking) water system, hospital and municipal wastewater treatment plants, and receiving rivers. Whole-genome sequencing will be performed to characterize CRPA isolates and determine the genetic relatedness among the isolates from different reservoirs. Findings from the cross-sectional study, combined with expert elicitation using a Delphi method, will serve as the input for the surveillance strategy. Conclusions: The SAMPAN study will provide a broader understanding of the sources and transmission routes of CRPA. Therewith, the development of a globally applicable smart surveillance strategy will be made possible, delivering information that is needed to guide actions against the spread of CRPA.


  • Open Access

    Creating Synergy: The Partnership Between Infection Prevention & Control Architectural Design for a Healthier Hospital

    by Margreet C. Vos, Anne F. Voor In ’T Holt, Juliëtte A. Severin, Adriënne S. van der Schoor

    The symbiotic relationship between healthy hospital design and infection prevention and control (IPC) is crucial to developing a safe healthcare environment. Collaborative efforts in mitigating the risk of hospital-acquired infections (HAIs) are needed and will decrease morbidity, mortality rates, and costs. HAIs not only impact patient health but also tarnish the reputation of healthcare institutions. This paper delves into the distinctions between exogenous-derived and endogenous-derived HAIs, elucidating their sources, transmission mechanisms, and preventive strategies. Exogenous-derived HAIs can be prevented by a well-designed hospital layout which minimize contamination. Endogenous-derived HAIs originate from the patient’s own microbial flora, necessitating tailored infection prevention strategies such as antimicrobial prophylaxis. Standard precautions and transmission-based precautions, as outlined by the Centers for Disease Control and Prevention (CDC), form the cornerstone of infection control efforts. Hospital design should facilitate compliance with these measures, ensuring a microbial-safe environment conducive to patient recovery. Interdisciplinary collaboration between architects, healthcare professionals, and infection control experts are needed to integrate infection control principles into hospital design processes effectively. Key considerations include optimizing patient flows, separating clean and dirty materials, and implementing robust ventilation systems to mitigate airborne transmission risks. Furthermore, selecting appropriate surface materials resistant to microbial growth and enabling effective cleaning and disinfection protocols are important to maintain a microbial safe hospital environment. Most importantly, the shift towards single-occupancy rooms represents a significant stride in infection prevention, minimizing the risk of cross-contamination compared to multi-occupancy wards. Scientific evidence supports the efficacy of single-occupancy rooms in reducing microbial contamination and preventing HAIs.


  • Open Access

    Co-occurrence of VIM-positive non- aeruginosa Pseudomonas spp. and Pseudomonas aeruginosa in the hospital: A detailed molecular comparison of bla VIM-2 -containing plasmids from environmental and clinical isolates

    by Jannette Pirzadian, Willemien H. A. Zandijk, Astrid P. Heikema, Heidy H. H. T. Koene, Wil H. F. Goessens, Margreet C. Vos, Corné H. W. Klaassen, Juliëtte A. Severin

    Background: Pseudomonas aeruginosa is a bacterial pathogen responsible for severe hospital-acquired infections, and is capable of forming persistent reservoirs in hospital sink drains, creating a transmission risk. In our hospital, we have cultured not only carbapenemase-producing, Verona Integron-encoded Metallo-beta-lactamase (VIM)-positive P. aeruginosa , but also VIM-positive non- aeruginosa Pseudomonas spp., from sink drains. Previously, a bla VIM-2 -containing, conjugative plasmid conferring carbapenem resistance was found in a clinical P. aeruginosa isolate in our hospital. Objective: To investigate if other Pseudomonas spp. from our hospital also carried a bla VIM-2 -containing plasmid, genetically characterize these plasmids, and compare these plasmids to publicly-available plasmid sequences to identify their source. Methods: Whole-genome sequencing was used to sequence chromosomes and possible plasmids from VIM-positive non- aeruginosa Pseudomonas spp. and VIM-positive P. aeruginosa strains. Hybrid assemblies were generated to reconstruct plasmid sequences. All isolates were obtained from environmental sampling or clinical cultures during a prolonged VIM-positive P. aeruginosa outbreak in our hospital. Results: An identical bla VIM-2 -containing plasmid was found in six non- aeruginosa Pseudomonas ( P. carnis , P. oleovorans , and a novel species) and in three P. aeruginosa isolates. The previously-reported bla VIM-2 -containing plasmid was found in three additional P. aeruginosa isolates. All P. aeruginosa belonged to high-risk clones ST111 or ST446. The two plasmids were derived from both clinical isolates and isolates from sink cultures, and were unique to our hospital when compared to other publicly-available plasmid sequences. Conclusions: During a VIM-positive P. aeruginosa outbreak in our hospital, two closely-related, bla VIM-2 -containing plasmids co-occurred in multiple non- aeruginosa Pseudomonas spp. and in high-risk P. aeruginosa clones ST111 and ST446. Non- aeruginosa Pseudomonas spp. cultured from either patient or sink samples may be important sources of carbapenem resistance genes, and should not be overlooked during outbreak investigations. Moreover, plasmid analysis is essential to fully understand transmission routes in hospitals.

  • Open Access

    Contact tracing for vancomycin-resistant Enterococcus faecium (VRE): evaluation of the Dutch policy of quintuple screening cultures

    by Linda J. Wammes, Anne F. Voor In ’t Holt, Corné H.W. Klaassen, Margreet C. Vos, Nelianne J. Verkaik, Juliëtte A. Severin

    Detection of vancomycin-resistant Enterococcus faecium (VRE) is hampered by low sensitivity of rectal swab cultures. This study aimed to define the number of screening cultures needed to increase sensitivity to detect VRE transmission, and to determine time from presumed exposure to detectable colonization. In a tertiary care setting, we retrospectively analyzed data from 9 VRE outbreaks. As a proxy or estimation for time to detectable colonization, the time between first positive culture of the presumed index patient and that of their contacts was determined. Only 64% of secondary cases were positive in the first out of five cultures. By using the first three out of five rectal swabs, 89% (95%CI: 78–95%) of all secondary cases would have been identified. The median number of days between the positive culture of the index patient and the first positive culture of secondary cases was 9 days. Eleven percent of secondary cases would have been missed if only three rectal samples would have been obtained. Furthermore, our results show that one or more rectal swabs taken around day 9 after presumed exposure should at least be included in the screening approach. In our setting, obtaining a fourth and a fifth rectal swab showed a relevant additional value compared to only one to three swabs. Our findings are useful for determining the most effective VRE contact tracing approach to prevent transmission.


  • Open Access

    Impact of sink design on bacterial transmission from hospital sink drains to the surrounding sink environment tested using a fluorescent marker

    by J. Pirzadian, T. Souhoka, M. Herweijer, L. van Heel, W.J.B. van Wamel, R.H.M. Goossens, J.A. Severin, M.C. Vos


  • Open Access

    Routes of transmission of VIM-positive Pseudomonas aeruginosa in the adult intensive care unit-analysis of 9 years of surveillance at a university hospital using a mathematical model

    by Thi Mui Pham, Andrea C. Büchler, Anne F. Voor In ‘t Holt, Juliëtte A. Severin, Martin C. J. Bootsma, Diederik Gommers, Mirjam E. Kretzschmar, Margreet C. Vos

    Background: Hospital outbreaks of multidrug resistant Pseudomonas aeruginosa are often caused by Pseudomonas aeruginosa clones which produce metallo-β-lactamases, such as Verona Integron-encoded Metallo-β-lactamase (VIM). Although different sources have been identified, the exact transmission routes often remain unknown. However, quantifying the role of different transmission routes of VIM-PA is important for tailoring infection prevention and control measures. The aim of this study is to quantify the relative importance of different transmission routes by applying a mathematical transmission model using admission and discharge dates as well as surveillance culture data of patients. Methods: We analyzed VIM-PA surveillance data collected between 2010 and 2018 of two intensive-care unit (ICU) wards for adult patients of the Erasmus University Medical Center Rotterdam using a mathematical transmission model. We distinguished two transmission routes: direct cross-transmission and a persistent environmental route. Based on admission, discharge dates, and surveillance cultures, we estimated the proportion of transmissions assigned to each of the routes. Results: Our study shows that only 13.7% (95% CI 1.4%, 29%) of the transmissions that occurred in these two ICU wards were likely caused by cross-transmission, leaving the vast majority of transmissions (86.3%, 95% CI 71%, 98.6%) due to persistent environmental contamination. Conclusions: Our results emphasize that persistent contamination of the environment may be an important driver of nosocomial transmissions of VIM-PA in ICUs. To minimize the transmission risk from the environment, potential reservoirs should be regularly and thoroughly cleaned and disinfected, or redesigned.